Nucana

Biotech stocks continued to remain under pressure in the week ended Sept. 11, swayed by the volatility that was evident in the broader market. The week also witnessed a flurry of news flow on the coronavirus vaccine front. Even as nine vaccine makers released a pledge to put safety first,...

Apparently biotech is where it’s at. This year’s expansive class of newly public pharmaceuticals will add three to its ranks with this week’s initial public offerings. Roku will also make its market debut after three years of speculated interest. Here is the entire lineup: RYB...